HemaSphere (Jun 2022)

PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE

  • Y. Bouchakor Moussa,
  • S. Taoussi,
  • S. Oukid,
  • F. Lamraoui,
  • N. Rekab,
  • K. M. Benlabiod,
  • H. Brahimi,
  • M. T. Abad,
  • M. Bradai

DOI
https://doi.org/10.1097/01.HS9.0000850440.38789.88
Journal volume & issue
Vol. 6
pp. 1776 – 1777

Abstract

Read online

No abstracts available.